The authors generated Fabp4-driven SREBP1c transgenic mice and showed that superphysiological overexpression of SREBP1c in adipose tissue impairs adipogenesis
When prescribed for weight management, the following drugs will soon be eligible for Part D coverage: Foundayo Wegovy (injection and oral tablet) Zepbound (mimics GLP-1s and another hormone, GIP) Medicare will also cover Wegovy for the risk reduction of major adverse cardiovascular events for those with established heart disease and/or who have obesity or are overweight
doi: 10.1039/D2NJ05094C 26 NaidjaA.HuangP
535 After FMT treatment, the proportion of proinflammatory Enterobacteriaceae decreased, the abundance of Collinsella increased, and the expression of IL-6 and IL-1 significantly decreased
This is great for weight loss, but it creates a margin forglp-1 medicationsblem
doi: 10.1016/j.cbi.2023.110835 52 PangCZhangHLiuYTangNTianKMuYet al